Enzolytics Inc (ENZC)

[falon]

No

It is not going to happen.

It is not LEGAL.

Case closed.

Here is what we are dealing with:

ENZC for the most part will be a shell of its former self when the company move all the valuable assets to the newly formed entity.

Normally for a SPAC deal the entire company is part of the business combination.

It did not happen in ENZC case for a number of reasons and here is a few:

1. Stock structure

2. Number of outstanding shares

3. Reporting status

4. Financial situation

5. Different share classes


If ENZC was in a position to due a normal SPAC deal and move the entire company then people wouldn't be confused, upset, concerned or whatever gripe they may have.

It doesn't matter what happens to ENZC the assets and focus are in the new company.

If anything becomes of ENZC, it will be icing on the cake however it will be minuscule as compared to what the newly formed company will produce.

The bottom line is and has always been can they deliver with the newly formed company.

Will we see success in Africa.

Will we see multiple clinical trials started soon after the money is in the bank.

Will we see licensing agreements.

The press releases over the past few months have been very positive, confident and upbeat as you would expect with the situation at hand.


There are Red Flags

1. SAGA not filing their reports on time - it is a minor issue however it happened with the 10K which they filed a month after getting a SEC delinquency notification letter and it happened again with the 10Q so I expect it to be filed by the end of the month (September 25) as they received a SEC delinquency notification letter on July 25, 2023.

2. Limited funds in the trust account will require a significant PIPE transaction.

3. Barry J. Kostiner failed to deliver SPAC deal with Sunfire Acquisition Corp Limited as Chief Financial Officer & Director. He is the Chief Executive Officer & Director in our SPAC.

One needs to be realistic about ENZC and what they do.

RESULTS have been very limited as to leading to revenue however the POTENTIAL of ENZC is through the ROOF.

Going to the NASDAQ is AAA.

We still now little about what is driving this and who the players are besides SAGA.

We don't who the NDAs are with and what they entail.

Is Big Pharma involved waiting in the wings to sign licensing/partnership deals.

As I said earlier and will say again the bottom line is:

Whether ENZC stayed as the are or move forward with SAGA, they must perform ie provide results by producing revenue and profit.

What will drive SAGA Scientific Holdings Corp. share price is results of operations such as announcing clinical trials and their results through different stages, licensing agreements, partnering and whatever else they can do to bring shareholder value.


It is all about comprehension - the action or capability of understanding something.

"Some don't have the least comprehension of what ENZC is trying to do"